South African COVID Variant Can 'Break Through' Pfizer Vaccine: Study
Order "It Takes a Revolution: Forget the Scandal Industry!" at BarnesandNoble.com
New York Post
April 11, 2021
JERUSALEM — The coronavirus variant discovered in South Africa can "break through" Pfizer/BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer-reviewed.
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease. It matched age and gender, among other characteristics.
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease. It matched age and gender, among other characteristics.
Order Klayman’s It Takes a Revolution: Forget the Scandal Industry!
How to wage a peaceful revolution to restore rule of law, ethics, and morality to the nation
With a title that satirically mocks Hillary Clinton, this book details how our executive, legislative, and judicial branches of government have become thoroughly corrupt and failed the citizenry. This work is a call to arms during these times of crises, when government corruption has hit a “cancerous state.” The overriding message is that Americans should turn off cable news, get up off of the couch, and join the second American Revolution to restore the greatness of our nation in these perilous times.
Support Our Cause and Join Our Fight!
Or call 844 FW ETHIC to contribute to Freedom Watch now
Your help is urgently needed!
Contact Freedom Watch at [email protected] or (424) 274 2579.
If this message was forwarded to you and you would like to receive future emails, sign up at https://www.freedomwatchusa.org/emails
Freedom Watch Inc.
2020 Pennsylvania Ave, NW
Suite 345
Washington, DC 20006
2020 Pennsylvania Ave, NW
Suite 345
Washington, DC 20006